Form 4 for GILD Gilead Sciences
Accepted 2023-07-26 00:00:00 ET · period of report 2023-07-25 · accession 0001127602-23-021338 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-26 | 2023-07-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | +10.3K | 8,607 | New | — |
| D | 2023-07-26 | 2023-07-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | F - Tax | $77.23 | -4,174 | 4,433 | -48% | -$322.4K |
| DM | 2023-07-26 | 2023-07-25 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | -10.3K | 32.9K | -24% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-25 | M | A | 2,058 | — | 6,491 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2023-07-25 | M | A | 8,231 | — | 8,607 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Common | Common Stock | 2023-07-25 | F | D | 4,174 | $77.23 | 4,433 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2023-07-25 | M | D | 8,231 | — | 34,909 | D | — · — to — | 8,231 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2023-07-25 | M | D | 2,058 | — | 32,851 | D | — · — to — | 2,058 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |